Raphael Pharmaceutical Inc. (RAPH) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$210.0K | +60.5% |
| 2024 | -$532.0K | +55.8% |
| 2023 | -$1.20M | -58.5% |
| 2022 | -$759.0K | +46.5% |
| 2021 | -$1.42M | -82.2% |
| 2020 | -$779.0K | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$210.0K | +60.5% |
| 2024 | -$532.0K | +55.8% |
| 2023 | -$1.20M | -58.5% |
| 2022 | -$759.0K | +46.5% |
| 2021 | -$1.42M | -82.2% |
| 2020 | -$779.0K | — |